SNIDER LINDY received a stock award from NEXIEN BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/7/2021ACC: 0001214659-21-006371
+250K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
250K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
52.1%
6/7/2021
480K→730K
Total
Net shares
+250K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 6/7/2021 | A · Award | +250K | — | — | 52.1% | 480K | 730K |
| Total | +250K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Stock option - right to buy
DirectUnderlying security
Common stock
Underlying shares
100K
Shares owned
100K
Exercise price
0.54
Expiration
—
Exercise window
—
Total
Underlying
100K
Owned
100K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock option - right to buy Direct | Common stock | 0.54 | — | — | 100K | 100K |
| Total | 100K | 100K | ||||